# A Safety and Efficacy Study of Paclitaxel-eluting Balloon to Paclitaxel-eluting Stent

> **NCT01622075** · PHASE3 · COMPLETED · sponsor: **B. Braun Medical International Trading Company Ltd.** · enrollment: 220 (actual)

## Conditions studied

- Coronary Instent Restenosis

## Interventions

- **DEVICE:** SeQuent® Please
- **DEVICE:** Taxus Liberte

## Key facts

- **NCT ID:** NCT01622075
- **Lead sponsor:** B. Braun Medical International Trading Company Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2013-04
- **Final completion:** 2014-04
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2015-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01622075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01622075, "A Safety and Efficacy Study of Paclitaxel-eluting Balloon to Paclitaxel-eluting Stent". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01622075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*